Canadian patent expands protection for neural sensing platform
Autonomix Medical received a Canadian patent for “Endoscopic Sympathectomy Systems and Methods,” expanding protection for its neural sensing platform.
The company said its global IP portfolio totals 112 issued or pending patent applications worldwide.
The patent covers real-time nerve sensing, mapping, physiological monitoring, and closed-loop feedback guidance for neuromodulation or denervation procedures.
Autonomix said related patents have already been issued in the US and Europe.